SAN FRANCISCO — A plaintiff who developed a severe reaction to the drug Motrin can pursue a punitive damages claim against Johnson & Johnson and one of its subsidiaries after the California Supreme Court on Wednesday declined to review the case.

The court also decided against depublishing the court of appeal decision denying Johnson & Johnson’s petition for a writ of mandate in the failure-to-warn case.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]